Higher vs lower heparin dose during planned heart stent procedure
Part of Heart & circulation clinical trials.
This trial compares a higher versus lower dose of heparin (a blood thinner) during a planned PCI, which is a heart procedure to open blocked arteries using a stent. It may help hospitals and patients know which dosing approach is safest and works well during the procedure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are age 18 or older.
- You are having an elective PCI (a planned stent procedure).
- Your procedure is not planned for a chronic total occlusion (a long-term, fully blocked artery).
- You are able to be followed through local hospital/registry follow-up.
- Your hospital agrees to use the trial’s higher- or lower-dose heparin approach during the study period.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two blood thinners, bivalirudin and heparin, given during a heart procedure to open blocked arteries (PCI). It aims to find which one is safer for people at high risk of bleeding.
This study compares two different daily doses of aspirin (50 mg vs 100 mg) when taken with a standard blood thinner (P2Y12 inhibitor) after getting a heart stent. It aims to see if a lower aspirin dose works just as well with fewer side effects.
This trial compares different LDL cholesterol targets to find the best level for people at very high risk after a heart stent procedure. It tests whether aiming for a lower cholesterol goal improves outcomes.
This trial tests an algorithm (computer-guided plan) to choose the best “dual antiplatelet therapy” (two blood-thinning medicines) after a coronary stent. It aims to improve outcomes after the procedure while reducing avoidable problems from the medicines.
This study looks at the best time to give a standard blood thinner (heparin) during a heart procedure called angioplasty, which opens blocked heart arteries through a wrist artery. It may help reduce bleeding or clotting risks.
This trial tests whether giving heparin (a blood thinner) during a specific type of heart procedure is safer and works better than not giving it. It focuses on patients where the blood supply in the hand’s artery connection is functioning properly.
Hear when a new Cardiovascular Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.